Pakistan Bait-ul-Mal (PBM), in partnership with the Zakat Foundation of America (ZFA), organized a “Training Programme and ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

HB1150 would ban the around 35 PBM-owned pharmacies in the state and prevent over 100 out-of-state PBM-owned pharmacies from ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Managing Director of Pakistan Bait-ul-Mal (PBM), Senator Capt. Shaheen Khalid Butt, instructed authorities to ensure quality ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...